Skip to main content
Premium Trial:

Request an Annual Quote

Applied Imaging Partners with Sanger to Develop Gene Expression Applications for Software

NEW YORK, April 29 - Applied Imaging is to be the exclusive imaging partner for the Wellcome Trust Sanger Institute's Atlas of Gene Expression project, the Santa Clara, Calif., company said today.

 

Under the agreement, Sanger will buy Applied Imaging's Ariol software for high-throughput analysis of tissue samples, which it will use for the Atlas of Gene Expression project. Applied will develop applications for the software that it will have commercial rights to sell.

 

The Atlas of Gene Expression project aims to globally map protein expression patterns in cells. The researchers will map expression in normal and disease states, and use recombinant antibodies for imaging and analysis, the Sanger Institute said.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.